<DOC>
	<DOCNO>NCT00897819</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood , urine , tissue patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . It may also help doctor predict patient respond treatment . PURPOSE : This laboratory study analyze DNA tissue sample patient advanced colorectal cancer treat fluorouracil oxaliplatin without bevacizumab clinical trial E-3200 .</brief_summary>
	<brief_title>Studying DNA Outcome Patients With Advanced Colorectal Cancer Treated With Fluorouracil Oxaliplatin With Without Bevacizumab Clinial Trial E-3200</brief_title>
	<detailed_description>OBJECTIVES : - Determine CpG island methylation pathway marker adverse survival treatment fluorouracil patient advance colorectal adenocarcinoma treat fluorouracil oxaliplatin without bevacizumab clinical trial E-3200 . - Compare methylation result clinicopathologic molecular finding survival . OUTLINE : This multicenter study . Tissue , blood , urine sample genomic DNA sample tumor tissue block examine pyrosequencing assay methylation . Genes examine include MINT1 , MINT31 , P14 , P16 . Microsatellite instability loss heterozygosity ( LOH ) chromosome 18 ( 18q LOH ) also assess . Microsatellites examine include BAT locus , TGFÎ²RII , D2S123 , D55346 , D17S250 . PROJECTED ACCRUAL : A total 350 specimen accrue study .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis adenocarcinoma colon rectum Advanced disease Enrolled clinical trial E3200 receive fluorouracil oxaliplatin Tumor tissue block available Routine pathology specimen ( i.e. , blood , urine ) available PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>recurrent colon cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
	<keyword>stage III colon cancer</keyword>
	<keyword>stage III rectal cancer</keyword>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>adenocarcinoma colon</keyword>
	<keyword>adenocarcinoma rectum</keyword>
</DOC>